Q3 FY2026 · ended Sep 30, 2026 · Revenue $75.83M, +26.2% YoY · Filed Oct 28, 2026
Axogen, Inc. (AXGN) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $75.8 million and net income of $2.3 million. Free cash flow was $15.1 million. As of Sep 30, 2026 it held $348.1 million in cash and investments and $19.5 million in total debt.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- AXGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MN
- Headquarters
- Alachua, FL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 805928
- Former names
- LECTEC CORP /MN/ (until Sep 29, 2011)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
- CapsoVision, Inc CV
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $75.8M | $69.7M | $61.5M | $59.9M | $60.1M |
| Operating income | $955,000 | -$2.2M | -$2.8M | -$9.8M | $1.9M |
| Net income | $2.3M | -$1.5M | -$19.6M | -$13.2M | $708,000 |
| Diluted EPS | $0.04 | -$0.03 | -$0.38 | -$0.28 | $0.01 |
| Operating cash flow | $16.5M | $7.2M | $1.6M | $3.0M | $3.2M |
| Free cash flow | $15.1M | $6.3M | -$1.2M | $1.8M | $1.7M |
| Total assets | $550.3M | $304.9M | $289.5M | $221.7M | $216.4M |
| Total liabilities | $54.2M | $48.6M | $44.7M | $92.8M | $95.6M |
| Stockholders' equity | $496.1M | $256.3M | $244.8M | $128.8M | $120.8M |
| Cash and investments | $348.1M | $111.4M | $101.6M | $41.5M | $35.8M |
| Total debt | $19.5M | $20.1M | $20.6M | $67.6M | $67.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 28, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2026 | Oct 1, 2026 |
| 8-K/A |
Amended current report
Material agreement, Regulation FD disclosure
|
Sep 10, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Sep 10, 2026 | Sep 9, 2026 |
| 10-Q | Quarterly report | Jul 29, 2026 | Jun 30, 2026 |
All 1000 Axogen, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.